 Connection
Ivor Douglas to Lung Diseases
This is a "connection" page, showing publications Ivor Douglas has written about Lung Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.204 |
|
|
|
-
Wilson KC, Gould MK, Krishnan JA, Boyd CM, Brozek JL, Cooke CR, Douglas IS, Goodman RA, Joo MJ, Lareau S, Mularski RA, Patel MR, Rosenfeld RM, Shanawani H, Slatore C, Sockrider M, Sufian B, Thomson CC, Wiener RS. An Official American Thoracic Society Workshop Report. A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Disease, Critical Illness, and Sleep Disorders. Ann Am Thorac Soc. 2016 Mar; 13(3):S12-21.
Score: 0.079
-
Douglas IS, Albertson TE, Folan P, Hanania NA, Tashkin DP, Upson DJ, Leone FT. Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup. Ann Am Thorac Soc. 2015 Nov; 12(11):1700-10.
Score: 0.078
-
Klein CL, Hoke TS, Fang WF, Altmann CJ, Douglas IS, Faubel S. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int. 2008 Oct; 74(7):901-9.
Score: 0.047
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|